...
首页> 外文期刊>British Journal of Cancer >Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment
【24h】

Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment

机译:一线或二线治疗使用帕尼单抗治疗的转移性结直肠癌患者的健康相关生活质量

获取原文
           

摘要

Background:Panitumumab in combination with chemotherapy was evaluated in two pivotal clinical trials in first- and second-line treatment of metastatic colorectal cancer (mCRC), respectively. This analysis compared the health-related quality of life (HRQoL) of patients with or without panitumumab in the two trials.
机译:背景:帕尼单抗联合化疗分别在转移性结直肠癌(mCRC)的一线和二线治疗的两项关键临床试验中进行了评估。该分析比较了两项试验中有或没有帕尼单抗的患者的健康相关生活质量(HRQoL)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号